The No statistical significant difference was found in the modification of cardiac frequency (P=0.136), of the median arterial pressure (P=0.128), in central venous pressure (P=0.384), cardiac output (P=0.092), and in Stroke Volume Variation (P=0.815) between the 2 groups. Recovery time in the Intensive Care Unit was 5±3 days for group 1 and 5±2 days for group 2.
Introduction
The improved knowledge of physiopathological changes due to surgical stress, the development of anesthesia and intensive care techniques have allowed for a more aggressive course of treatment in patients before considered inoperable and terminally ill. This holds true in the oncological field, allowing for more radical responses in care. [1] [2] [3] Cytoreductive surgery (CRS) and hyperthermic intraoperative chemotherapy (HIPEC), first developed in the 1990s, has become an important therapeutic option for selected patients with peritoneal surface malignancies. Aim of this approach is complete elimination of malignant tumor to increase disease free survival and overall survival of patients affected by advanced neoplastic disease. 4 CRS and HIPEC fall into the high-risk category of abdominal surgery due to their long operating time and significant loss of liquids, blood, plasma, and proteins. Every patients candidate to CRS and HIPEC have to be carefully evaluated and selected before to be submitted to different phases of HIPEC with its own potential surgical risk. [5] [6] [7] The cytoreduction phase involves the isolation and removal of the parietal peritoneum, visceral peritoneum, and the debulking of tumor mass with multi visceral resection. Furthermore, cytoreduction surgery requires a substantial reshuffling of the circulatory and microcirculatory distribution and consequently alteration to the hydro-electrical and acid-base equilibrium. 8 The chemohyperthermia phase, lasting about 90 min (60-120 min), consists of continuous cycling infusion of chemotherapeutics ranging from 40° to 42°C. The infusion is carried out by an external circuit that heats and distributes the chemotherapeutics at a speed of 600-1000 ml/min, to guarantee a temperature of approximately 41°C in whole peritoneal cavity.
Significant peripheral vasodilation, caused by hyperthermia, results in a series of systemic repercussions that vary depending on the perfusion technique implemented. Generally, the procedure is performed through a median laparotomy, providing exposure for a complete meticulous exploration for peritoneal deposits followed by peritoneal and organ resection.
The peritoneal route of chemotherapy is based on the peritoneal plasma partition concept that allows a high concentration of the chemotherapy to be in direct contact with cancerous cells with minimal systemic absorption and side effects. The most commonly used chemotherapeutic agents are mitomycin-c, oxaliplatin, irinotican and cisplatin. The addition of heat to the chemotherapy potentiates the activity of some chemotherapeutic agents and increase diffusion of the chemotherapeutic agents between the cells.
Intra-operative chemo-hyperthermia can be administrated with different techniques: abdominal wall can be left open or closed during the HIPEC therapy period.
In the open coliseum technique, the abdominal wall is elevated to create a funnel to accommodate the heated chemotherapy that circulates through inflow and outflow lines attached to a pump and heating unit. This technique provides that HIPEC is completed prior to the closure of the abdomen cavity. Lifting the edges of the surgical wound upwards and suspending them under traction by threads from a retractor positioned above the abdomen facilitates approach to the peritoneal cavity, optimizes exposure of intra-abdominal organs.
In the closed method, the skin is temporary closed after placing the inflow and outflow tubing through separated incisions. In the laparoscopic approach, the abdominal cavity is filled with the HIPEC solution that circulates using a pump with a heating unit, through laparoscopic incisions.
During the reconstruction phase, surgeon re-establishes the physiological anatomy of abdomen, and anesthesist restores normal volume and temperature.
The aim of this study is to investigate and analyze clinical outcomes in patients submitted to CS and HIPEC.
Materials and Methods
We carried out a retrospective observational study involving 30 patients submitted to CS and HIPEC in the Department of Surgery of St. Orsola-Malpighi Hospital (Bologna, Italy) between may 2012 and may 2013. We divided patients into 2 groups: Group 1, consisting of 15 patients underwent open-abdomen HIPEC (coliseum technique) and Group 2, consisting of 15 patients underwent close-abdomen HIPEC.
Detailed anesthesiologic preoperative evaluation of every patient was made before surgery. This included also an informed consent, signed by the patient, in which an anesthesiologist is listed as responsible for administering pre-operative medication.
General anesthesia was administered by opioids, halothane, sleep inducing and muscle relaxation drugs. To better control intraoperative and postoperative pain, epidural analgesia was administrated by thoracic catheter. [9] [10] [11] [12] [13] [14] [15] In Table 1 we summarized advantages of thoracic epidural anesthesia.
To ensure a close monitoring of the patient's vital parameters a standard system of Electrocardiography, capnometer, pulse oxymeter was used associated to FloTrac/Vigileo® technology, to check cardiac index (CI), cardiac output (CO), and stroke volume variation (SVV). 16 Naso-gastric tube and double-lumen bladder catheter with urinometer were positioned after induction of general anesthesia. 17 Statistical analysis was mad by SPSS IBM Statistics program. Neoplastic diseases affected our population study was summarized in Table 2 .
Thermal regulation was assured by ZERO HEAT FLUX TECH-NOLOGY (3M®).

Results
Group
Surgical time was 650±128 min for group 1 and 637±71 minutes for group 2.
Hemodynamic stability was monitored in both groups during the chemo-perfusion phase. No statistical significant difference was found in the modification of cardiac frequency (P=0.136), variation of the median arterial pressure (P=0.128), changes in central venous pressure (P=0.384), CO (P=0.092), and in SVV (P=0.815) between the 2 groups.
No catecholamines were administered in our patients. Volumetric and fluid filling was done by crystalloid perfusion at an average speed of 12/15 mL/kg/h in group 1 and 8/12 mL/kg/h in group 2. Perfusion speed was modulated by a continuous administration of diuretics to ensure an hourly diuresis of 0.8-1.5 mL/kg/h.
On average, 1513±966 mL of concentrated homologous red blood cells, 1076±746 mL of fresh, frozen plasma and 513±255 mL of 20% albumin was administrated in group 1.
An average of 1496±875 mL of concentrated homologous red blood cells, 1020±527 mL of fresh, frozen plasma, and 310±145 mL of 20% albumin was administered in group 2.
Adverse events were classified according to the Common Terminology Criteria for Adverse Events v3.0 (CTCAE). 18 Adverse events Grade ½ was found in 22% of patients; adverse events of Grade 3 was found in 8% of patients, requiring further surgery or recovery in the Intensive Care Unit (ICU).
Mean length hospital stay in ICU was 5±3 days for group 1 and 5±2 days for group 2.
Mean length hospital stay was 17±6 days for group 1 and 20±11 days for group 2. Our data does not provide substantial support for one method over the other.
Article
In our experience there is a small difference in the endoabdominal temperature, between closed and open technique. The closed technique results in a faster increase in central temperature that does not interfere with the chemo-perfusion procedure.
In regards to the possible dispersion and vaporization of various types of antineoplastic agents during the chemo-perfusion phase, contamination of personnel, taking appropriate clothing and protection is improbable 19, 20 even if one must always consider the words of Favier who wrote: There will be always doubts, and these should benefit those concerned through a continual search for ways to minimize contact by adapting procedures. 21 This approach to advanced neoplastic disease with peritoneal carcinomatosis requires advanced anesthesia administration and an experienced operating team. 22 Anesthetic management importantly contributes to the containment of the perioperative complications of HIPEC. Only with a dedicated team of surgeons and anesthesiologists with adequate learning curve, 23 careful to fluid exchange, hematic and protein loss, we can decrease peri-and post-operative complications and morbidity rate. 
